Gang Wang
Gang Wang
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Baihe Han
Baihe Han
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Ruoxi Zhang
Ruoxi Zhang
3
Department of Cardiology, Harbin Yinghua Hospital, Harbin, China
3,
Qi Liu
Qi Liu
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Xuedong Wang
Xuedong Wang
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Xingtao Huang
Xingtao Huang
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Dandan Liu
Dandan Liu
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Weishen Qiao
Weishen Qiao
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Mengyue Yang
Mengyue Yang
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Xing Luo
Xing Luo
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,
Jingbo Hou
Jingbo Hou
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2,*,
Bo Yu
Bo Yu
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
1,2
1
The Key Laboratory of Myocardial Ischemia Organization, Chinese Ministry of Education, Harbin, China
2
Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
3
Department of Cardiology, Harbin Yinghua Hospital, Harbin, China
Edited and reviewed by:
Francesco Rossi, University of Campania Luigi Vanvitelli, Italy
✉*Correspondence: Jingbo Hou, jingbohou@163.com
This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology
Received 2021 Nov 10; Accepted 2021 Nov 22; Collection date 2021.
Keywords: CTRP9, atherosclerosis, senescence, hyperglycemia, AMPK, KLF4
Copyright © 2021 Wang, Han, Zhang, Liu, Wang, Huang, Liu, Qiao, Yang, Luo, Hou and Yu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.